Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year […]
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average 1-year […]
